Citation Impact
Citing Papers
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Hepatocellular carcinoma screening in patients waiting for liver transplantation: A decision analytic model
2003
Prognostic significance of c‐myc and AIB1 amplification in hepatocellular carcinoma
2002
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma
2011
Hepatocellular carcinoma
2018 Standout
Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis
2009
Large (≥5.0-cm) HCCs: Multipolar RF Ablation with Three Internally Cooled Bipolar Electrodes—Initial Experience in 26 Patients
2008
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
2017
Hepatocellular carcinoma
2012 Standout
Hepatocellular carcinoma
2021 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
HPK1 competes with ADAP for SLP‐76 binding and via Rap1 negatively affects T‐cell adhesion
2010 StandoutNobel
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
2012
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
2012 Standout
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
2005 StandoutNobel
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Global cancer statistics
2011 Standout
Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study
2016
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
2005
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
2012 Standout
MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies
2008
Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
2011
Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
1995
Multiple treg suppressive modules and their adaptability
2012 StandoutNobel
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
2009 StandoutNature
A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma
2005
Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD Score
2008
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
2011
PIVKA-II Is the Best Prognostic Predictor in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation Therapy
2008
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Tailoring T-cell receptor signals by proximal negative feedback mechanisms
2008
Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow
2002
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Percutaneous Ethanol Injection Versus Surgical Resection for the Treatment of Small Hepatocellular Carcinoma
2005
Hepatocellular Carcinoma
2011 Standout
Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma
2009
Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model
2004 StandoutNobel
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Development and Selection of T Cells: Facts and Puzzles
1995
Requirement of the IL-2 Receptor β Chain for the Development of Vγ3 Dendritic Epidermal T Cells
1998
Percutaneous radiofrequency ablation for hepatocellular carcinoma
2005
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
Both integrated and differential regulation of components of the IL-2/IL-2 receptor system
2006
Hepatocellular carcinoma
2022 Standout
TRANCE, a TNF Family Member, Is Differentially Expressed on T Cell Subsets and Induces Cytokine Production in Dendritic Cells
1999 StandoutNobel
Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β
1995 Science
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms
2009 StandoutNobel
Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma
2007
Facilitation of β Selection and Modification of Positive Selection in the Thymus of Pd-1–Deficient Mice
2000 StandoutNobel
Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
2012 StandoutNobel
JAKS AND STATS: Biological Implications
1998 Standout
Impaired development of V gamma 3 dendritic epidermal T cells in p56lck protein tyrosine kinase-deficient and CD45 protein tyrosine phosphatase-deficient mice.
1995
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
Interleukin 15: biology and relevance to human disease
2001
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
Increased T Cell Autoreactivity in the Absence of CD40-CD40 Ligand Interactions: A Role of CD40 in Regulatory T Cell Development
2001 StandoutNobel
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma
2013
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.
1994
Liver Transplantation for Malignancy
2005
A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma
2006
Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation
2009
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus
2004
CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
1994
Abnormal Development of Intestinal Intraepithelial Lymphocytes and Peripheral Natural Killer Cells in Mice Lacking the IL-2 Receptor β Chain
1997
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
2011
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Thymus and Autoimmunity: Production of CD25+CD4+ Naturally Anergic and Suppressive T Cells as a Key Function of the Thymus in Maintaining Immunologic Self-Tolerance
1999 StandoutNobel
CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production
1998 Standout
Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells.
1996
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
CD1 Recognition by Mouse NK1 + T Lymphocytes
1995 StandoutScience
Defective Lymphoid Development in Mice Lacking Jak3
1995 StandoutScienceNobel
Differential Roles of Cytokine Receptors in the Development of Epidermal γδ T Cells
2001 StandoutNobel
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses
2012 StandoutNobel
Works of Keisuke Hamamura being referenced
Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma
2008
Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial
2004
Nonsurgical Treatment of Hepatocellular Carcinoma: From Percutaneous Ethanol Injection Therapy and Percutaneous Microwave Coagulation Therapy to Radiofrequency Ablation
2002
Expression and role of interleukin‐2 receptor β chain on CD4−CD8+ T cell receptor αβ+ cells
1992
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-?-carboxy prothrombin and low serum ?-fetoprotein
2000
Risk Factors for Recurring Hepatocellular Carcinoma Differ According to Infected Hepatitis Virus—An Analysis of 236 Consecutive Patients With A Single Lesion
2000
Hepatocellular carcinoma in elderly patients
2002
Percutaneous ethanol injection therapy for liver tumors
2001
In utero treatment with monoclonal antibody to IL-2 receptor β-chain completely abrogates development of Thy-1+ dendritic epidermal cells
1992
Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
2004
Clinical features of patients with HCC who are negative for both HBV and HCV markers.
2004
Prospective randomized controlled trial comparing percutaneous radiofrequency ablation and percutaneous ethanol injection therapy for small hepatocellular carcinoma
2000